Cochrane Abstracts
Erythromycin for the prevention of chronic lung disease in intubated preterm infants at risk for, or colonized or infected with Ureaplasma urealyticum Edited (no change to conclusions)
Erythromycin for the prevention of chronic lung disease in intubated preterm infants at risk for, or colonized or infected with Ureaplasma urealyticum Edited (no change to conclusions) is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Erythromycin for the Prevention of Chronic Lung Disease in Intubated Preterm Infants at Risk For, or Colonized or Infected With Ureaplasma Urealyticum Edited (no Change to Conclusions)." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432559/all/Erythromycin_for_the_prevention_of_chronic_lung_disease_in_intubated_preterm_infants_at_risk_for__or_colonized_or_infected_with_Ureaplasma_urealyticum_Edited__no_change_to_conclusions_. Accessed 28 January 2023.
Erythromycin for the prevention of chronic lung disease in intubated preterm infants at risk for, or colonized or infected with Ureaplasma urealyticum Edited (no change to conclusions). Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432559/all/Erythromycin_for_the_prevention_of_chronic_lung_disease_in_intubated_preterm_infants_at_risk_for__or_colonized_or_infected_with_Ureaplasma_urealyticum_Edited__no_change_to_conclusions_. Accessed January 28, 2023.
Erythromycin for the prevention of chronic lung disease in intubated preterm infants at risk for, or colonized or infected with Ureaplasma urealyticum Edited (no change to conclusions). In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432559/all/Erythromycin_for_the_prevention_of_chronic_lung_disease_in_intubated_preterm_infants_at_risk_for__or_colonized_or_infected_with_Ureaplasma_urealyticum_Edited__no_change_to_conclusions_
Erythromycin for the Prevention of Chronic Lung Disease in Intubated Preterm Infants at Risk For, or Colonized or Infected With Ureaplasma Urealyticum Edited (no Change to Conclusions) [Internet]. In: Cochrane Abstracts. [cited 2023 January 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432559/all/Erythromycin_for_the_prevention_of_chronic_lung_disease_in_intubated_preterm_infants_at_risk_for__or_colonized_or_infected_with_Ureaplasma_urealyticum_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Erythromycin for the prevention of chronic lung disease in intubated preterm infants at risk for, or colonized or infected with Ureaplasma urealyticum Edited (no change to conclusions)
ID - 432559
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432559/all/Erythromycin_for_the_prevention_of_chronic_lung_disease_in_intubated_preterm_infants_at_risk_for__or_colonized_or_infected_with_Ureaplasma_urealyticum_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -
